Nuveen, LLC Biomarin Pharmaceutical Inc Call Options Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMRN
# of Institutions
650Shares Held
183MCall Options Held
1.98MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.4 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.17 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.09 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$905 Million0.61% of portfolio
-
Viking Global Investors LP10.5MShares$645 Million2.34% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...